Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Complicated Relationship between Gaucher Disease and Parkinsonism: Insights from a Rare Disease
Elma Aflaki, Wendy Westbroek, Ellen Sidransky
Neuron (2017) Vol. 93, Iss. 4, pp. 737-746
Open Access | Times Cited: 148

Showing 26-50 of 148 citing articles:

Pathological role of lipid interaction with α-synuclein in Parkinson's disease
Mari Suzuki, Kazunori Sango, Keiji Wada, et al.
Neurochemistry International (2018) Vol. 119, pp. 97-106
Open Access | Times Cited: 64
Augmented frontal cortex diacylglycerol levels in Parkinson’s disease and Lewy Body Disease
Paul L. Wood, Soumya Tippireddy, Joshua Feriante, et al.
PLoS ONE (2018) Vol. 13, Iss. 3, pp. e0191815-e0191815
Open Access | Times Cited: 63
Impaired β-glucocerebrosidase activity and processing in frontotemporal dementia due to progranulin mutations
Andrew E. Arrant, Jonathan R. Roth, Nicholas R. Boyle, et al.
Acta Neuropathologica Communications (2019) Vol. 7, Iss. 1
Open Access | Times Cited: 56
Astrocyte dysfunction in Parkinson's disease: from the perspectives of transmitted α-synuclein and genetic modulation
Changjing Wang, Tongtong Yang, Meiyu Liang, et al.
Translational Neurodegeneration (2021) Vol. 10, Iss. 1
Open Access | Times Cited: 48
Autophagy-Lysosomal Pathway as Potential Therapeutic Target in Parkinson’s Disease
Srinivasa Reddy Bonam, Christine Tranchant, Sylviane Muller
Cells (2021) Vol. 10, Iss. 12, pp. 3547-3547
Open Access | Times Cited: 45
Targeting neuronal lysosomal dysfunction caused by β-glucocerebrosidase deficiency with an enzyme-based brain shuttle construct
Alexandra Gehrlein, Vinod Udayar, Nadia Anastasi, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 22
Post-translational proteomics platform identifies neurite outgrowth impairments in Parkinson’s disease GBA-N370S dopamine neurons
Helle Bogetofte, Brent J. Ryan, Pia Jensen, et al.
Cell Reports (2023) Vol. 42, Iss. 3, pp. 112180-112180
Open Access | Times Cited: 21
The annotation of GBA1 has been concealed by its protein-coding pseudogene GBAP1
Emil K. Gustavsson, Siddharth Sethi, Yujing Gao, et al.
Science Advances (2024) Vol. 10, Iss. 26
Open Access | Times Cited: 8
Path mediation analysis reveals GBA impacts Lewy body disease status by increasing α-synuclein levels
Anna Lisa Gündner, Gonzalo Durán-Pacheco, Silke Zimmermann, et al.
Neurobiology of Disease (2018) Vol. 121, pp. 205-213
Closed Access | Times Cited: 54
A Compendium of Information on the Lysosome
Nadia Bouhamdani, Dominique Comeau, Sandra Turcotte
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 39
GCase Enhancers: A Potential Therapeutic Option for Gaucher Disease and Other Neurological Disorders
Macarena Martínez‐Bailén, Francesca Clemente, Camilla Matassini, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 7, pp. 823-823
Open Access | Times Cited: 23
Glucocerebrosidase activity and lipid levels are related to protein pathologies in Parkinson’s disease
Cheryl E. G. Leyns, Alice Prigent, Brenna Beezhold, et al.
npj Parkinson s Disease (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 14
α-Synuclein: Multiple pathogenic roles in trafficking and proteostasis pathways in Parkinson’s disease
Annie J. Zalon, Drew J. Quiriconi, Caleb Pitcairn, et al.
The Neuroscientist (2024) Vol. 30, Iss. 5, pp. 612-635
Closed Access | Times Cited: 5
Plasma and platelet lipidome changes in Fabry disease
Bo Burla, Jeongah Oh, Albina Nowak, et al.
Clinica Chimica Acta (2024) Vol. 562, pp. 119833-119833
Open Access | Times Cited: 5
High Glucosylceramides and Low Anandamide Contribute to Sensory Loss and Pain in Parkinson's Disease
Katharina Klatt‐Schreiner, Lucie Valek, Jun‐Suk Kang, et al.
Movement Disorders (2020) Vol. 35, Iss. 10, pp. 1822-1833
Open Access | Times Cited: 35
Classic and evolving animal models in Parkinson's disease
Tanvi Pingale, Girdhari Lal Gupta
Pharmacology Biochemistry and Behavior (2020) Vol. 199, pp. 173060-173060
Closed Access | Times Cited: 35
Longitudinal clinical, cognitive, and neuroanatomical changes over 5 years in GBA-positive Parkinson’s disease patients
Michela Leocadi, Elisa Canu, Giulia Donzuso, et al.
Journal of Neurology (2021) Vol. 269, Iss. 3, pp. 1485-1500
Closed Access | Times Cited: 30
Pathogenesis of Parkinson’s disease: from hints from monogenic familial PD to biomarkers
Nobutaka Hattori, Manabu Funayama, Yuzuru Imai, et al.
Journal of Neural Transmission (2024) Vol. 131, Iss. 6, pp. 709-719
Closed Access | Times Cited: 4
Normal and Dysregulated Sphingolipid Metabolism: Contributions to Podocyte Injury and Beyond
Matthew Tolerico, Sandra Merscher, Alessia Fornoni
Cells (2024) Vol. 13, Iss. 11, pp. 890-890
Open Access | Times Cited: 4
Electric-field induced sleep promotion and lifespan extension in Gaucher's disease model flies
Takaki Nedachi, Haruhisa Kawasaki, Eiji Inoue, et al.
Biochemistry and Biophysics Reports (2025) Vol. 41, pp. 101915-101915
Closed Access
Glucocerebrosidase haploinsufficiency in A53T α-synuclein mice impacts disease onset and course
Nahid Tayebi, Loukia Parisiadou, Bahafta Berhe, et al.
Molecular Genetics and Metabolism (2017) Vol. 122, Iss. 4, pp. 198-208
Open Access | Times Cited: 35
Computational modelling approaches as a potential platform to understand the molecular genetics association between Parkinson’s and Gaucher diseases
D. Thirumal Kumar, Hend Ghasan Eldous, Zainab Alaa Mahgoub, et al.
Metabolic Brain Disease (2018) Vol. 33, Iss. 6, pp. 1835-1847
Closed Access | Times Cited: 33
Can GBA1-Associated Parkinson Disease Be Modeled in the Mouse?
Tamar Farfel‐Becker, Jenny Do, Nahid Tayebi, et al.
Trends in Neurosciences (2019) Vol. 42, Iss. 9, pp. 631-643
Closed Access | Times Cited: 32
Roles of VMP1 in Autophagy and ER–Membrane Contact: Potential Implications in Neurodegenerative Disorders
Panpan Wang, Daqing Kou, Weidong Le
Frontiers in Molecular Neuroscience (2020) Vol. 13
Open Access | Times Cited: 31
Gaucher disease and SARS-CoV-2 infection: Emerging management challenges
Pramod K. Mistry, Manisha Balwani, Deborah Barbouth, et al.
Molecular Genetics and Metabolism (2020) Vol. 130, Iss. 3, pp. 164-169
Open Access | Times Cited: 31

Scroll to top